Clinical Trial Update: Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of early-line anti-EGFR therapy to facilitate retreatment in select patients with metastatic colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING